MDNews - Eastern Pennsylvania/Northwest New Jersey

January/February 2013

Issue link: https://viewer.e-digitaledition.com/i/101407

Contents of this Issue

Navigation

Page 25 of 27

+++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ ++++++++++++++++++++++++++++ ++++++++++++++++++++++++++++ ++++++++++++++++++++++++++++ ++++++++++++++++++++++++++++ ++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ +++++++++++++++++++++++++++++++++++++++++++++++++ thAt���snews ��������� New Test Measures autism Risk a tEaM of Australian researchers led by University of Melbourne recently developed a test to assess infants��� and children���s risk for developing autism spectrum disorder (ASD). The research team used U.S. data from 3,346 Cord Blood Cells May Potentially treat IBD individuals with ASD and 4,165 of their relatives nEw rEsEarcH supportEd by the participating in the Autism Genetic Resource National Heart, Lung and Blood Institute Exchange (AGRE) and Simons Foundation suggests a special population of stem Autism Research Initiative (SFARI). Of these, cells found in cord blood can potentially they identified 237 genetic markers (single- treat inflammatory bowel disease (IBD) by nucleotide polymorphisms) in 146 genes and migrating to the intestine and contributing related cellular pathways that either contribute to the cell population there. to or protect individuals from developing ASD. The test measures genetic markers for both risk and protection from ASD. An Researchers studied this population of cells ��� called endothelial colony-forming increased score on the genetics test indicates a greater risk, while a lower score indicates cells ��� which are found in cord blood, bone protective markers. marrow and circulating blood. They evalu- The test proved more than 70% accurate when tested on people of central European ated the population���s potential to migrate descent. Validation tests are ongoing and include the progression of accurate testing for to the intestine and treat the dysfunctional other origins. ��� blood vessels symptomatic of IBD. Findings indicated the cells can contribute to blood vessel formation not only in embryos, but in adults as well, sparking the idea of using them for therapy. Researchers injected the cells into fetal sheep at 59 to 65 days gestation. They analyzed intestinal tissue approximately 11 weeks later and detected the presence of the human cells. They found the human cells migrated to the healthy intestine and survived in the cell population there, showing potential to support vascular health. The next step is to determine if cells have the ability to survive in an inflamed intestine. ��� A dv e r t i s e r s ��� i n d e x Blue Ridge Country Club ........................ 26 Easton Hospital.........................Back Cover Fitzpatrick Lentz & Bubba ..................... 24 Hand & Upper Extremity.................... Inside Back Cover Knopf Audi .................................................. 23 Moravian Hall Square ................ Inside Back Cover Nixon Uniform ..............Inisde Back Cover Susan Bella Jewelry ................................. 22 26 | Eastern Pennsylvania/NW New Jersey MD News ��� MdnEws.coM ��� January/fEBruary 2013

Articles in this issue

Archives of this issue

view archives of MDNews - Eastern Pennsylvania/Northwest New Jersey - January/February 2013